IA5_2H1W

General Information


DRACP ID  DRACP05543

Peptide Name   IA5_2H1W

Sequence  XACHGRRWGCGRHRGRCG

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  All cysteines form disulfide bridges with the T3-scaffold.

N-terminal Modification  FITC

C-terminal Modification  Amidation

Other Modification  X=Ahx, 6-aminohexanoic acid

Chiral  L



Physicochemical Information


Formula  C75H119N37O17S3

Absent amino acids  DEFIKLMNPQSTVY

Common amino acids  GR

Mass  232060

Pl  11.9

Basic residues  7

Acidic residues  0

Hydrophobic residues  2

Net charge  7

Boman Index  -7124

Hydrophobicity  -125

Aliphatic Index  5.56

Half Life 
  /

Extinction Coefficient cystines  5625

Absorbance 280nm  330.88

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24697151

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2385

DRACP is developed by Dr.Zheng's team.